Inventor · disambiguated record
Leslie Dakin
Also filed as: DAKIN LESLIE · DAKIN LESLIE A
8 granted patents·15 pending applications·34 citations·filing 2005–2024
83Inventor score
Top patents by PatentIndex Score
23 records- 0192US11866446B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·7 cites·55 claims
- 0291US12060346B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2023·Granted Aug 13, 2024·1 cites·53 claims
- 0391US11618746B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2019·Granted Apr 4, 2023·6 cites·28 claims
- 0484US8901307B2Chemical compounds 251DAKIN LESLIE·Filed 2009·Granted Dec 2, 2014·15 cites·5 claims
- 0582US12281102B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Apr 22, 2025·1 cites·38 claims
- 0682US12116343B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2021·Granted Oct 15, 2024·1 cites·33 claims
- 0778US2025042878A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 0876US7723337B23-cinnolinecarboxamide derivatives and their use for treating cancerASTRAZENECA AB·Filed 2008·Granted May 25, 2010·3 cites·11 claims
- 0971US12421249B2Inhibitors of APOL1 and methods of using sameVERTEX PHARMA·Filed 2023·Granted Sep 23, 2025·0 cites·23 claims
- 1060US2025136612A14',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1160US2025195483A1Spiro piperidine derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1259US2025171459A12-methyl-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1357US2025163021A12-methyl-4-phenylpiperidin-4-ol derivatives as inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1457US2023203000A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1556US2025084094A1Spirocyclic inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2022·Application pending·0 cites
- 1653US2023014907A1Inhibitors of apol1 and methods of using sameVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 1749US2015051185A1Chemical Compounds 251ASTRAZENECA AB·Filed 2014·Application pending·0 cites
- 1849US2009270450A1Chemical compoundsASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1948US2009054411A14-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitorsASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2047US2010311748A1Heterocyclic amides useful for the treatment of cancer and psoriasisASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2143US2008312206A1Chemical Compounds-149ASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2241US2011098283A13-cinnolinecarboxamide derivatives and their use for treating cancerASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 2339US2009118261A1Quinazolinone derivatives and their use as b-raf inhibitorsASTRAZENECA AB·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Leslie Dakin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →